COMPANY

Athersys

HQ: Cleveland, OH source · athersys.com ↗ · Midwest

Keywords: regenerative medicine cell therapy neurology cardiovascular cardiovascular disease ischemic stroke

Location: Cleveland, OH · source · Oct 15, 2026

Profile checked Oct 10, 2026

25NIH grants

NIH awards 25

Annual award amounts. Total $7.9M.

Aug 21, 2017 NIH award 5R42AA024003-03 FY2017: $293,537 awarded for that fiscal year; activity R42 (STTR); PI TING, ANTHONY; recipient as written: ATHERSYS, INC., CLEVELAND, OH. Cell Therapy for the Treatment of Acute Respiratory source ↗
Aug 31, 2016 NIH award 4R42AA024003-02 FY2016: $450,040 awarded for that fiscal year; activity R42 (STTR); PI TING, ANTHONY; recipient as written: ATHERSYS, INC., CLEVELAND, OH. Cell Therapy for the Treatment of Acute Respiratory source ↗
Mar 10, 2016 NIH award 5R44HL117572-03 FY2016: $842,506 awarded for that fiscal year; activity R44 (SBIR); PI TING, ANTHONY; recipient as written: ATHERSYS, INC., CLEVELAND, OH. Phase II Trial Evaluating the Safety and Efficacy o source ↗
Jul 10, 2015 NIH award 1R43NS090688-01A1 FY2015: $212,796 awarded for that fiscal year; activity R43 (SBIR); PI BUSCH, SARAH; recipient as written: ATHERSYS, INC., CLEVELAND, OH. Combinatorial Treatment of Acute Spinal Cord Injur source ↗
Jan 26, 2015 NIH award 4R44HL117572-02 FY2015: $865,500 awarded for that fiscal year; activity R44 (SBIR); PI TING, ANTHONY; recipient as written: ATHERSYS, INC., CLEVELAND, OH. Phase II Trial Evaluating the Safety and Efficacy o source ↗
Sep 24, 2014 NIH award 1R42AA024003-01A1 FY2014: $224,721 awarded for that fiscal year; activity R42 (STTR); PI TING, ANTHONY; recipient as written: ATHERSYS, INC., CLEVELAND, OH. Cell Therapy for the Treatment of Acute Respirato source ↗
Aug 29, 2014 NIH award 5U44NS077511-03 FY2014: $595,424 awarded for that fiscal year; activity U44 (SBIR); PI MAYS, ROBERT WILLIAM; recipient as written: ATHERSYS, INC., CLEVELAND, OH. Cell Based Therapy for Treatment of Traumati source ↗
Aug 28, 2013 NIH award 4U44NS077511-02 FY2013: $959,795 awarded for that fiscal year; activity U44 (SBIR); PI MAYS, ROBERT WILLIAM; recipient as written: ATHERSYS, INC., CLEVELAND, OH. Cell Based Therapy for Treatment of Traumati source ↗
Aug 1, 2013 NIH award 1R44HL117572-01A1 FY2013: $330,000 awarded for that fiscal year; activity R44 (SBIR); PI TING, ANTHONY; recipient as written: ATHERSYS, INC., CLEVELAND, OH. Phase II Trial Evaluating the Safety and Efficacy source ↗
Jan 31, 2012 NIH award 1U44NS077511-01 FY2012: $299,999 awarded for that fiscal year; activity U44 (SBIR); PI MAYS, ROBERT WILLIAM; recipient as written: ATHERSYS, INC., CLEVELAND, OH. Cell Based Therapy for Treatment of Traumati source ↗
Aug 24, 2010 NIH award 1R43HL105071-01 FY2010: $99,302 awarded for that fiscal year; activity R43 (SBIR); PI DEANS, ROBERT; recipient as written: ATHERSYS, INC., CLEVELAND, OH. Optimization of the angiogenic potential of multipot source ↗
Nov 20, 2009 NIH award 5R42NS055606-04 FY2010: $392,223 awarded for that fiscal year; activity R42 (STTR); PI CARROLL, JAMES EDWIN; recipient as written: ATHERSYS, INC., CLEVELAND, OH. Stem Cells for Neonatal Hypoxic-Ischemic Bra source ↗
Mar 12, 2009 NIH award 3R42NS055606-03S1 FY2009: $392,223 awarded for that fiscal year; activity R42 (STTR); PI CARROLL, JAMES EDWIN; recipient as written: ATHERSYS, INC., CLEVELAND, OH. Stem Cells for Neonatal Hypoxic-Ischemic B source ↗
Feb 5, 2009 NIH award 5R42NS055606-03 FY2009: $204,829 awarded for that fiscal year; activity R42 (STTR); PI CARROLL, JAMES EDWIN; recipient as written: ATHERSYS, INC., CLEVELAND, OH. Stem Cells for Neonatal Hypoxic-Ischemic Bra source ↗
Sep 28, 2007 NIH award 2R42NS055606-02A1 FY2007: $205,471 awarded for that fiscal year; activity R42 (STTR); PI BORLONGAN, CESARIO V; recipient as written: ATHERSYS, INC., CLEVELAND, OH. Stem Cells for Neonatal Hypoxic-Ischemic B source ↗
Sep 15, 2006 NIH award 1R41NS055606-01 FY2006: $136,500 awarded for that fiscal year; activity R41 (STTR); PI CARROLL, JAMES EDWIN; recipient as written: ATHERSYS, INC., CLEVELAND, OH. Stem Cells for Neonatal Hypoxic-Ischemic Bra source ↗
Aug 26, 2004 NIH award 1R43HL078024-01 FY2004: $100,000 awarded for that fiscal year; activity R43 (SBIR); PI VAN'T HOF, WOUTER J; recipient as written: ATHERSYS, INC., CLEVELAND, OH. In-vitro generation of cardiomyocytes from MA source ↗
Aug 16, 2004 NIH award 5R44NS041712-03 FY2004: $349,047 awarded for that fiscal year; activity R44 (SBIR); PI HARRINGTON, JOHN J; recipient as written: ATHERSYS, INC., CLEVELAND, OH. Genome-Wide Growth Factor Discovery in the CNS source ↗
Jul 29, 2004 NIH award 1R43CA110707-01 FY2004: $99,944 awarded for that fiscal year; activity R43 (SBIR); PI HARRINGTON, JOHN J; recipient as written: ATHERSYS, INC., CLEVELAND, OH. Small Molecular Inhibitors of Artemis as Radios source ↗
Mar 1, 2004 NIH award 1R43CA109205-01 FY2004: $99,990 awarded for that fiscal year; activity R43 (SBIR); PI SHERF, BRUCE A; recipient as written: ATHERSYS, INC., CLEVELAND, OH. Development of NFkappaB Inhibitors source ↗
Mar 1, 2004 NIH award 1R43HD046177-01 FY2004: $99,850 awarded for that fiscal year; activity R43 (SBIR); PI HARRINGTON, JOHN J; recipient as written: ATHERSYS, INC., CLEVELAND, OH. Autologous cell therapy with SMC modified MAPCs source ↗
Aug 18, 2003 NIH award 2R44NS041712-02 FY2003: $385,357 awarded for that fiscal year; activity R44 (SBIR); PI HARRINGTON, JOHN J; recipient as written: ATHERSYS, INC., CLEVELAND, OH. Genome-Wide Growth Factor Discovery in the CNS source ↗
Jul 1, 2003 NIH award 1R43AI056636-01 FY2003: $99,800 awarded for that fiscal year; activity R43 (SBIR); PI JACKSON, P. DAVID; recipient as written: ATHERSYS, INC., CLEVELAND, OH. Drug Target Discovery in Mast Cells by GECKO Tec source ↗
Sep 10, 2001 NIH award 1R43NS041712-01 FY2001: $99,111 awarded for that fiscal year; activity R43 (SBIR); PI HARRINGTON, JOHN J; recipient as written: ATHERSYS, INC., CLEVELAND, OH. Genome-Wide Growth Factor Discovery in the CNS source ↗
May 15, 2001 NIH award 1R43AR047748-01 FY2001: $99,111 awarded for that fiscal year; activity R43 (SBIR); PI HARRINGTON, JOHN J; recipient as written: ATHERSYS, INC., CLEVELAND, OH. Use of Genome-Wide Protein Expression Libraries source ↗